Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines

International Journal of Cancer

Volumn 65, Issue 2, 1996, Pages 230-237

  Izquierdo, Miguel A ^a   Shoemaker, Robert H ^b   Flens, Marcel J ^a   Scheffer, George L ^a   Wu, Lin ^b   Prather, Tanya R ^b   Scheper, Rik J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; ANTINEOPLASTIC AGENT; BLEOMYCIN; BUSULFAN; CHLORAMBUCIL; CYTARABINE; DACTINOMYCIN; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GLYCOPROTEIN P; HYDROXYUREA; LOMUSTINE; MERCAPTOPURINE; MULTIDRUG RESISTANCE PROTEIN; TIOGUANINE; VINBLASTINE; VINCRISTINE;

ARTICLE; CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; TUMOR CELL LINE;

ATP-BINDING CASSETTE TRANSPORTERS; DRUG RESISTANCE, MULTIPLE; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; TUMOR CELLS, CULTURED; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 0030032909     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960117)65:2<230::AID-IJC17>3.0.CO;2-H     Document Type: Article

References (26)

1. ALVAREZ, M., PAULL, K., MONKS, A., HOSE, C., LEE, J-S., WEINSTEIN, J., GREVER, M., BATES, S. and FOJO, T., Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute anticancer drug screen. J. clin. Invest., 95, 2205-2214 (1995).
2. BECK, W.T., DANKS, M.K., WOLVERTON, J.S., KIM, R. and CHEN, M., Drug resistance associated with altered DNA-topoisomerase-I. Advanc. Enzyme Reg., 33, 113-127 (1993).
3. BRADLEY, G. and LING, V., P-glycoprotein, multidrug resistance and tumor progression. Cancer Metast. Rev., 13, 223-233 (1994).
4. CHUGANI, D.C., ROME, L.H. and KEDERSHA, N.L., Evidence that vault ribonucleoprotein particles localize to the nuclear pore complex. J. Cell Sci., 106, 23-29 (1993).
5. COLE, S.P.C., BHARDWAJ, G., GERLACH, J.H., MACKIE, J.E., GRANT, C.E., ALMQUIST, K.C., STEWART, A.J., KURZ, E.U., DUNCAN, A.M.V. and DEELEY, R.G., Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science (Wash.), 258, 1650-1654 (1992).
6. DIETEL, M., ARPS, H., LAGE, H. and NIENDORF, A., Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line PG85-257. Cancer Res., 50, 6100-6106 (1990).
7. EIJDEMS, E.W.H.M., ZAMAN, G.J.R., DE HAAS, M., VERSANTVOORT, C.H.M., FLENS, M.J , SCHEPER, R.J., KAMST, E., BORST, P. and BAAS, F., Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells. Brit. J Cancer, 72, 298-306 (1995).
8. FLENS, M.J., IZQUIERDO, M.A., SCHEFFER, G.L., FRITZ, J.M., MEIJER, C.J.L.M., SCHEPER, R.J. and ZAMAN, G.J.R., Immunochemical detection of MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Res, 54, 4557-4563 (1994).
9. FRANCKE, U., DARRAS, B.T., ZANDER, N.F. and KILIMANN, M.W., Assignment of human genes for phosphorylase kinase subunits a (PHKA) to Xq12-13 and β (PHKB) to 16q12-q13. Amer. J. hum. Genet., 45, 276-282 (1989).
10. FUTSCHER, B.W., ABBASZADEGAN, M.R., DOMANN, F. and DALTON, W.S., Analysis of MRP mRNA in mitoxantrone-selected, multidrug-resistance human tumor cells. Biochem. Pharmacol., 47, 1601-1604 (1994).
11. IZQUIERDO, M.A., VAN DER VALK, P., SCHEFFER, G.L., FLENS, M., BROXTERMAN, H.J., MEIJER, C.J.L.M. and SCHEPER, R.J., Distribution in normal human tissues and tumors of a 110 kD protein associated with non P-glycoprotein multidrug resistance. Proc. Amer. Ass. Cancer. Res , 34, 311 (abst. 1849) (1993).
12. IZQUIERDO, M.A., VAN DER ZEE, A., VERMORKEN, J., VAN DER VALK, P., BELIEN, J., GIACCONE, G., SCHEFFER, G.L. FLENS, M.J., KENEMANS, J., PINEDO, H.M., MEIJER, C.J.L.M., DE VRIES, E.G.E. and SCHEPER, R.J., The drug resistance-associated marker LRP predicts poor response to platinum-alkylating chemotherapy and outcome in advanced ovarian carcinoma. J. nat. Cancer Inst., 87, 1230-1237 (1995).
13. KRAMER, R., WEBER, T.K., MORSE, B., ARCECI, R., STANIUNAS, R., STEELE, G., JR. and SUMMERHAYES, L.C., Constitutive expression of multidrug resistance in human colorectal tumours and cell lines. Brit J. Cancer, 67, 959-968 (1993).
14. KUIPER, C.M., BROXTERMAN, H.J., BAAS, F., SCHUURHUIS, G.J., HAISMA, H.J., SCHEFFER, G.L., LANKELMA, J. and PINEDO, H.M., Drug transport variants without P-glycoprotein over-expression from a human squamous-lung-cancer cell line after selection with doxorubicin. J. cell. Pharmacol., 1, 35-41 (1990).
15. LIST, A.F., SPIER, C.S., ABBASZADEGAN, M., GROGAN, T.M., GREER, J.P., WOLFF, S.N., SCHEPER, R.J. and DALTON, W.S., Non-P-glycopiotein (PGP) mediated multidrug resistance (MDR): identification of a novel drug resistance phenotype with prognostic relevance in acute myeloid leukemia (AML). Blood, 82, 443a (abst. 1755) (1993).
16. MONKS, A., SCUDIERO, D., SKEHAN, P., SHOEMAKER, R.H., PAUL, K., VISTICA, D., HOSEE, C., LANGLEY, J., CRONISE, P., VAIGRO-WOLFF, A., GRAY-GOODRICH, M., CAMPBELL, H., MAYO, J. and ROYD, M., Feasibility of high-efflux anticancer drug screening using a diverse panel of cultured human tumor cell lines. J. nat. Cancer Inst., 83, 757-766 (1991).
17. MULLER, M., MEIJER, C., ZAMAN, G.J.R., BORST, P., SCHEPER, R.J., MULDER, N.H., DE VRIES, E.G.E. and JANSEN, P.L.M., Overexpression of the multidrug resistance associated protein (MRP) gene results in increased ATP-dependent glutathione S-conjugate transport. Proc. nat. Acad. Sci. (Wash.), 91, 13033-13037 (1994).
18. ROME, L., KEDERSHA, N. and CHUGANI, D., Unlocking vaults: organelles in search of a function. Trends Cell Biol., 1, 47-50 (1991).
19. SCHEFFER, G.L., WUNGAARD, P.L.J., FLENS, M.J., IZOUIERDO, M.A., SLOVACK, M.L., PINEDO, H.M., MEIJER, C.J.L.M., CLEVERS, H.C. and SCHEPER, R.J., The drug resistance related protein LRP is the human major vault protein. Nature Med., 1, 578-582 (1995).
20. SCHEPER, R.J., BROXTERMAN, H.J., SCHEFFER, G.L., KAAIJK, P., DALTON, W.S., VAN HEIJNINGEN, T.H.M., VAN KALKEN, C.K., SLOVAK, M.L., DE VRIES, E.G.E., VAN DER VALK, P., MEIJER, C.J.L.M. and PINEDO, H.M., Overexpression of a 110 kD vesicular protein in non-P-glycoprotein mediated multidrug-resistance. Cancer Res., 53, 1475-1479 (1993).
21. SCHUURHUIS, G.J., BROXTERMAN, H.J., DE LANGE, J.H.M., PINEDO, H.M., VAN HEIJNINGEN, T.H.M., KUIPER, C.M., SCHEFFER, G.L., SCHEPER, R.J., VAN KALKEN, C.K., BAAK, J.P.A. and LANKELMA, J., Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein. Brit. J. Cancer, 64, 857-861 (1991).
22. SLAPAK, C.A., FRACASSO, P.M., MARTELL, R.L., TOPPMEYER, D.L., LECERF, J.M. and LEVY, S.B., Overexpression of the Multidrug Resistance-associated Protein (MRP) gene in vincristine but not in doxorubicin-selected multidrug-resistant murine erythroleukemia cells. Cancer Res, 54, 5607-5613 (1994).
23. SLOVAK, M.L., HO, J., DEELEY, R.G., COLE, S.P.C., DE VRIES, E.G.E., BROXTERMAN, H., SCHEFFER, G.L. and SCHEPER, R.J., The drug resistance related protein LRP maps proximal to MRP on the short arm of chromosome 16. Proc. Amer. Ass. Cancer Res., 36, 19 (abst. 114) (1995).
24. VOLM, M., KASTEL, M., MATTERN, J. and EFFERTH, T., Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas. Cancer, 71, 3981-3987 (1993).
25. WU, L., SMYTHE, A.M., STINSON, S.F., MULLENDORE, L.A., MONKS, A., SCUDIERO, D.A., PAULL, K.D., KOUTSOUKOS, A.D., RUBINSTEIN, L.V., BOYD, M.R. and SHOEMAKER, R.H., Multidrug-resistant phenotype of disease-oriented panels of human tumor cell tines used for anticancer drug screening. Cancer Res., 52, 3029-3034 (1992).
26. ZAMAN, G.J.R., FLENS, M.J., VAN LEUSDEN, M.R., DE HAAS, M., MULDER, H.S., LANKELMA, J., PINEDO, H.M., SCHEPER, R.J., BAAS, F., BROXTERMAN, H.J. and BORST, P., The human multidrug resistance-associated protein (MRP) is a plasma membrane drug efflux pump. Proc. nat. Acad. Sci. (Wash.), 91, 8822-8826 (1994).